Research Article

Correlation of Neuroimaging Findings with Clinical Presentation and Laboratory Data in Patients with COVID-19: A Single-Center Study

Table 2

Brain imaging results of 436 COVID-19 patients.

VariableValue

Brain CT ()
 Time of first CT exam (days)7 (6-9)
 No abnormality265 (62.7)
 Infarction15 (3.5)
 Intracranial hemorrhage8 (1.9)
 Nonspecific white matter changes135 (31.9)
Brain MRI ()
 Time of first MR exam (days)8 (6-10)
 Intracranial hemorrhage (for SWI)10 (4.1)
 Nonspecific white matter changes123 (50.6)
Location of nonspecific white matter changes ()
 Frontal lobe78 (63.4)
 Parietal lobe68 (55.3)
 Temporal lobe32 (26.0)
 Occipital lobe25 (20.3)
 Pons-mesencephalon19 (15.4)
 Basal ganglia32 (26.0)
 Corpus callosum12 (9.8)
 Periventricular41 (33.3)
 Cerebellar7 (5.7)
CTA ()
 Occlusion8 (44.4)
 Right MCA5 (62.5)
 Left MCA1 (12.5)
 Left PCA2 (25.0)
MRA ()
 Occlusion5 (45.5)
 Right MCA3 (60.0)
 Right PCA1 (20.0)
 Venous sinus thrombosis1 (20.0)
DWI ()
 Time of first diffusion exam (days)8 (6-10)
 Infarction46 (28.2)
 Infarction site
 Right hemisphere13 (28.3)
 Left hemisphere12 (26.1)
 Both hemisphere18 (39.1)
 Cerebellum3 (6.5)

Interval between diagnosis of COVID-19 and first brain imaging exam.